Small cell carcinoma of the larynx. 1994

L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
Department of Otolaryngology, Cukurova University Medical Faculty, Adana, Turkey.

UI MeSH Term Description Entries
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
March 1990, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
February 1988, Ear, nose, & throat journal,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
March 2000, Acta otorrinolaringologica espanola,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 1975, Ceskoslovenska patologie,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 1994, Auris, nasus, larynx,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 1989, Auris, nasus, larynx,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 1979, The Annals of otology, rhinology, and laryngology,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 2000, Anales otorrinolaringologicos ibero-americanos,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
January 1985, American journal of otolaryngology,
L Soylu, and C Ozcan, and F Cetik, and S Paydaş, and M Kiroğlu, and B Aydoğan, and I Tuncer, and A Javadzadeh, and B Sahin, and C Ozsahinoğlu
October 1997, Auris, nasus, larynx,
Copied contents to your clipboard!